The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
Open accessAbstract
White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationDebette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
White matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284
Williamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246 · cited 1×
“This trial demonstrated reduced mild cognitive impairment in the intensive treatment arm (though this was not a primary endpoint of the trial) [59].”
BackgroundDiagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000034 · Cited by 852
Self-citationHeterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P., & Geurts, J. J. G. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204685 · Cited by 766
Impact of multiple pathologies on the threshold for clinically overt dementia
Kapasi, A., DeCarli, C., & Schneider, J. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1717-7 · Cited by 739 · cited 4×
“Brain vascular pathology is an important comorbidity in the multietiology view of common sporadic dementias of aging [14].”
BackgroundResultInfluentialSelf-citationVascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Self-citationHypertension and cerebral white matter lesions in a prospective cohort study
de Leeuw, F. ‐., de Groot, J. C., Oudkerk, M., Witteman, J. C. M., Hofman, A., van Gijn, J., & Breteler, M. M. B. (2002) · Brain · doi:10.1093/brain/awf077 · Cited by 614
van Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., Vermeulen, M., & van Gool, W. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30950-3 · Cited by 611
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587
van Dijk, E. J., Prins, N. D., Vrooman, H. A., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2008) · Stroke · doi:10.1161/strokeaha.107.513176 · Cited by 580
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542
Longstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke · doi:10.1161/01.str.0000149625.99732.69 · Cited by 474
Dufouil, C., Chalmers, J., Coskun, O., Besançon, V., Bousser, M.-G., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.501163 · Cited by 461
Association of midlife blood pressure to late-life cognitive decline and brain morphology
Swan, G. E., DeCarli, C., Miller, B. L., Reed, T., Wolf, P. A., Jack, L. M., & Carmelli, D. (1998) · Neurology · doi:10.1212/wnl.51.4.986 · Cited by 388
Gouw, A. A., van der Flier, W. M., Fazekas, F., van Straaten, E. C. W., Pantoni, L., Poggesi, A., Inzitari, D., Erkinjuntti, T., Wahlund, L. O., Waldemar, G., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.498535 · Cited by 384
Presence and progression of white matter hyperintensities and cognition: A meta-analysis
Kloppenborg, R. P., Nederkoorn, P. J., Geerlings, M. I., & van den Berg, E. (2014) · Neurology · doi:10.1212/wnl.0000000000000505 · Cited by 338 · cited 2×
“A systematic review concluded that WMHs explain a modest degree of crosssectional variation in cognition and cognitive decline [3].”
BackgroundNeuropathologic correlates of white matter hyperintensities
Young, V. G., Halliday, G. M., & Kril, J. J. (2008) · Neurology · doi:10.1212/01.wnl.0000319691.50117.54 · Cited by 336 · cited 1×
“These data are broadly confirmed by more recent molecular studies [38,39].”
ResultHeterogeneity in age-related white matter changes
Schmidt, R., Schmidt, H., Haybaeck, J., Loitfelder, M., Weis, S., Cavalieri, M., Seiler, S., Enzinger, C., Ropele, S., Erkinjuntti, T., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0851-x · Cited by 328
White matter hyperintensities and normal-appearing white matter integrity in the aging brain
Maniega, S. M., Valdés Hernández, M. C., Clayden, J. D., Royle, N. A., Murray, C., Morris, Z., Aribisala, B. S., Gow, A. J., Starr, J. M., Bastin, M. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.048 · Cited by 277
McAleese, K. E., Walker, L., Graham, S., Moya, E. L. J., Johnson, M., Erskine, D., Colloby, S. J., Dey, M., Martin-Ruiz, C., Taylor, J.-P., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1738-2 · Cited by 273
Sexton, C. E., Betts, J. F., Demnitz, N., Dawes, H., Ebmeier, K. P., & Johansen-Berg, H. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.09.071 · Cited by 254
Clinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 249
Deep white matter infarction: correlation of MR imaging and histopathologic findings.
Marshall, V. G., Bradley, W. G., Marshall, C. E., Bhoopat, T., & Rhodes, R. H. (1988) · Radiology · doi:10.1148/radiology.167.2.3357964 · Cited by 243
Simpson, J. E., Fernando, M. S., Clark, L., Ince, P. G., Matthews, F., Forster, G., O'Brien, J. T., Barber, R., Kalaria, R. N., Brayne, C., et al. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00828.x · Cited by 215
Bolandzadeh, N., Davis, J. C., Tam, R., Handy, T. C., & Liu-Ambrose, T. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-126 · Cited by 212
Egaña-Gorroño, L., López-Díez, R., Yepuri, G., Ramirez, L. S., Reverdatto, S., Gugger, P. F., Shekhtman, A., Ramasamy, R., & Schmidt, A. M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00037 · Cited by 211
White matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K., Ihara, M., & Kalaria, R. N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 208
White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study
Verdelho, A., Madureira, S., Moleiro, C., Ferro, J. M., Santos, C. O., Erkinjuntti, T., Pantoni, L., Fazekas, F., Visser, M., Waldemar, G., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7ca05 · Cited by 192
Self-citationCoevolution of white matter hyperintensities and cognition in the elderly
Maillard, P., Carmichael, O., Fletcher, E., Reed, B., Mungas, D., & DeCarli, C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182617136 · Cited by 172
Kohama, S. G., Rosene, D. L., & Sherman, L. S. (2011) · AGE · doi:10.1007/s11357-011-9357-7 · Cited by 153
Self-citationJoutel, A., & Chabriat, H. (2017) · Clinical Science · doi:10.1042/cs20160380 · Cited by 147
Alzheimer's Disease–Related Dementias Summit 2016: National research priorities
Corriveau, R. A., Koroshetz, W. J., Gladman, J. T., Jeon, S., Babcock, D., Bennett, D. A., Carmichael, S. T., Dickinson, S. L.-J., Dickson, D. W., Emr, M., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004717 · Cited by 147
Self-citationMediterranean Diet and White Matter Hyperintensity Volume in the Northern Manhattan Study
Gardener, H. E., Scarmeas, N., Gu, Y., Boden-Albala, B., Elkind, M. S. V., Sacco, R. L., DeCarli, C., & Wright, C. B. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.548 · Cited by 141
Associations between amyloid β and white matter hyperintensities: A systematic review
Roseborough, A. D., Ramirez, J., Black, S. E., & Edwards, J. D. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.026 · Cited by 139
Self-citationShobin, E., Bowley, M. P., Estrada, L. I., Heyworth, N. C., Orczykowski, M. E., Eldridge, S. A., Calderazzo, S. M., Mortazavi, F., Moore, T. L., & Rosene, D. L. (2017) · GeroScience · doi:10.1007/s11357-017-9965-y · Cited by 137
Self-citationBolandzadeh, N., Tam, R. C., Handy, T. C., Nagamatsu, L. S., Hsu, C. L., Davis, J. C., Dao, E. A., Beattie, B. L., & Liu-Ambrose, T. Y. L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13644 · Cited by 125
Cognitive impairment risk: White matter hyperintensity progression matters
Silbert, L. C., Howieson, D. B., Dodge, H., & Kaye, J. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ad53fd · Cited by 123
Espeland, M. A., Erickson, K. I., Neiberg, R. H., Jakicic, J. M., Wadden, T. A., Wing, R. R., Desiderio, L. M., Erus, G., Hsieh, M.-K., Davatzikos, C. A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2230 · Cited by 115
Effect of pravastatin on cerebral infarcts and white matter lesions
ten Dam, V. H., van den Heuvel, D. M. J., van Buchem, M. A., Westendorp, R. G. J., Bollen, E. L. E. M., Ford, I., de Craen, A. J. M., & Blauw, G. J. (2005) · Neurology · doi:10.1212/01.wnl.0000161844.00797.73 · Cited by 113 · cited 1×
“Statins Nearly three years of treatment with 40 mg of pravastatin daily in the Pravastatin in elderly individuals at risk of vascular disease (PROSPER) study did not reduce WMH progression over the placebo group in individuals with increased vascular risk [61].”
BackgroundFish consumption and risk of subclinical brain abnormalities on MRI in older adults
Virtanen, J. K., Siscovick, D. S., Longstreth, W. T., Kuller, L. H., & Mozaffarian, D. (2008) · Neurology · doi:10.1212/01.wnl.0000324414.12665.b0 · Cited by 107
Arvanitakis, Z., Fleischman, D. A., Arfanakis, K., Leurgans, S. E., Barnes, L. L., & Bennett, D. A. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1034-7 · Cited by 105
Neuropathology of White Matter Lesions, Blood–Brain Barrier Dysfunction, and Dementia
Hainsworth, A. H., Minett, T., Andoh, J., Forster, G., Bhide, I., Barrick, T. R., Elderfield, K., Jeevahan, J., Markus, H. S., & Bridges, L. (2017) · Stroke · doi:10.1161/strokeaha.117.018101 · Cited by 105
Self-citationWallin, A., Kapaki, E., Boban, M., Engelborghs, S., Hermann, D. M., Huisa, B. N., Jonsson, M. A. G., Kramberger, M. G., Lossi, L., Malojčić, B., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0877-3 · Cited by 98
Self-citationPeriventricular hyperintensities are associated with elevated cerebral amyloid
Marnane, M., Al-Jawadi, O., Mortazavi, S. A., Pogorzelec, K. J., Wang, B. W., Feldman, H., Hsiung, G. R., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002352 · Cited by 95
Self-citationBrickman, A. M., Schupf, N., Manly, J. J., Stern, Y., Luchsinger, J. A., Provenzano, F. A., Narkhede, A., Razlighi, Q. R., Collins‐Praino, L. E., Artéro, S., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.07.155 · Cited by 88
Self-citationCerebral amyloid angiopathy as a cause of neurodegeneration
Smith, E. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14157 · Cited by 86
Richard, E., Gouw, A. A., Scheltens, P., & van Gool, W. A. (2010) · Stroke · doi:10.1161/strokeaha.109.571281 · Cited by 82
Rosario, B. L., Rosso, A. L., Aizenstein, H. J., Harris, T. B., Newman, A. B., Satterfield, S., Studenski, S. A., Yaffe, K. S., Rosano, C., & Study, F. T. H. A. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv224 · Cited by 77
Dallaire‐Théroux, C., Callahan, B. L., Potvin, O., Saïkali, S., & Duchesne, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161028 · Cited by 76
Self-citationJorgensen, D. R., Shaaban, C. E., Wiley, C. A., Gianaros, P. J., Mettenburg, J., & Rosano, C. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00535.2017 · Cited by 76
Self-citationPeak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
Low, A., Mak, E., Stefaniak, J. D., Malpetti, M., Nicastro, N., Savulich, G., Chouliaras, L., Markus, H. S., Rowe, J. B., & O'Brien, J. T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00238 · Cited by 71
Swardfager, W., Yu, D., Ramirez, J., Cogo‐Moreira, H., Szilagyi, G. M., Holmes, M. F., Scott, C. J. M., Scola, G., Chan, P. C., Chen, J., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.011 · Cited by 58
Self-citationIn Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T
Shaaban, C. E., Aizenstein, H. J., Jorgensen, D. R., MacCloud, R. L., Meckes, N. A., Erickson, K. I., Glynn, N. W., Mettenburg, J., Guralnik, J. M., Newman, A. B., et al. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5327 · Cited by 53
Self-citationHabes, M., Erus, G., Toledo, J. B., Bryan, R. N., Janowitz, D., Doshi, J. J., Völzke, H., Schminke, U., Hoffmann, W. U., Grabe, H. J., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.02.002 · Cited by 52
The role of cerebrovascular disease when there is concomitant Alzheimer disease
Vemuri, P., & Knopman, D. S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.013 · Cited by 49
Self-citationVuorinen, M., Spulber, G., Damangir, S., Niskanen, E., Ngandu, T., Soininen, H., Kivipelto, M., & Solomon, A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-140924 · Cited by 48
Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI
Guio, F. D., Vignaud, A., Chabriat, H., & Jouvent, É. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17690164 · Cited by 45
Swardfager, W., Yu, D., Scola, G., Cogo‐Moreira, H., Chan, P., Zou, Y. Z., Herrmann, N., Lanctôt, K. L., Ramirez, J., Gao, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.029 · Cited by 38
Self-citationWard, S. A., Raniga, P., Ferris, N. J., Woods, R. L., Storey, E., Bailey, M., Brodtmann, A. G., Yates, P. A., Donnan, G. A., Trevaks, R. E., et al. (2016) · International Journal of Stroke · doi:10.1177/1747493016669848 · Cited by 37
Edwards, J. D., Ramirez, J., Callahan, B. L., Tobe, S. W., OH, P. I., Berezuk, C., Lanctôt, K. L., Swardfager, W., Nestor, S. M., Kiss, A., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170238 · Cited by 29
Self-citationFlavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
Shishtar, E., Rogers, G. T., Blumberg, J. B., Au, R., DeCarli, C. S., & Jacques, P. F. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa068 · Cited by 25
Yang, D., Huang, L., Luo, C., Li, M., Qin, R., Ma, J., Shao, P., Xu, H., Zhang, B., Xu, Y., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00250 · Cited by 22
White, W. B., Jalil, F., Wakefield, D. B., Kaplan, R. F., Bohannon, R. W., Hall, C. B., Moscufo, N., Fellows, D., Guttmann, C. R. G., & WOLFSON, L. I. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.08.002 · Cited by 21
Graham, L. C., Kocalis, H. E., Soto, I., & Howell, G. R. (2020) · eNeuro · doi:10.1523/eneuro.0057-20.2020 · Cited by 19
Yamano, S., Horii, M., Takami, T., Sakuma, M., Morimoto, T., Okada, S., Taoka, T., Kichikawa, K., Sasamura, H., Itoh, H., et al. (2013) · International Journal of Stroke · doi:10.1111/ijs.12085 · Cited by 10
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Hypertension-induced cognitive impairment: From pathophysiology to public health
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., & Csiszar, A. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00430-6 · Cited by 544
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Ossenkoppele, R., Lyoo, C. H., Jester-Broms, J., Sudre, C. H., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R., Strandberg, O., Palmqvist, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.5154 · Cited by 161
White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution
Garnier‐Crussard, A., Cotton, F., Krolak‐Salmon, P., & Chételat, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13057 · Cited by 139
Metadata
- Authors
- Alber, J., Alladi, S., Bae, H., Barton, D. A., Beckett, L. A., Bell, J. M., Berman, S. E., Biessels, G. J., Black, S. E., Bos, I., Bowman, G. L., Brai, E., Brickman, A. M., Callahan, B. L., Corriveau, R. A., Fossati, S., Gottesman, R. F., Gustafson, D. R., Hachinski, V., Hayden, K. M., Helman, A. M., Hughes, T. M., Isaacs, J. D., Jefferson, A. L., Johnson, S. C., Kapasi, A., Kern, S., Kwon, J. C., Kukolja, J., Lee, A., Lockhart, S. N., Murray, A., Osborn, K. E., Power, M. C., Price, B. R., Rhodius‐Meester, H. F. M., Rondeau, J. A., Rosen, A. C., Rosene, D. L., Schneider, J. A., Scholtzova, H., Shaaban, C. E., Silva, N. C. B. S., Snyder, H. M., Swardfager, W., Troen, A. M., van Veluw, S. J., Vemuri, P., Wallin, A., Wellington, C., Wilcock, D. M., Xie, S. X., & Hainsworth, A. H.
- Venue
- Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Publisher
- Wiley
- Published
- 2019-01
- Volume
- 5
- Issue
- 1
- Pages
- 107-117
- ISSN
- 2352-8737 (ISSN-L)
- OpenAlex
- W2936365596
- Cited by
- 443
- References
- 67
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.